Chisako Sato

Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

T. Wajima, N. Kawaguchi, T. Ishibashi, 2018, Clinical Drug Investigation.

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes

F. Hayden, T. Uehara, S. Omoto, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Baloxavir Marboxil 2% Granules in Japanese Children With Influenza

T. Uehara, P. Piedra, T. Ishibashi, 2020, The Pediatric infectious disease journal.

Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study

T. Uehara, T. Ishida, A. Watanabe, 2019, Antiviral research.